Celadon Pharmaceuticals (LSE:CEL) FCF Yield % : -13.00 (As of May. 02, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Celadon Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-8.35 Mil, and Market Cap is €64.21 Mil. Therefore, Celadon Pharmaceuticals's FCF Yield % for today is -13.00%.

The historical rank and industry rank for Celadon Pharmaceuticals's FCF Yield % or its related term are showing as below:

LSE:CEL' s FCF Yield % Range Over the Past 10 Years
Min: -17.79 Med: 0 Max: 0
Current: -13

LSE:CEL's FCF Yield % is ranked worse than
78.74% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.62 vs LSE:CEL: -13.00

Celadon Pharmaceuticals's FCF Margin % for the quarter that ended in Jun. 2023 was -41,455.56%.

Celadon Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Celadon Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals FCF Yield % Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

FCF Yield %

-30.22

Celadon Pharmaceuticals Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
FCF Yield %	Get a 7-Day Free Trial			-	-	-16.49	-29.66	-8.02

Competitive Comparison of Celadon Pharmaceuticals's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celadon Pharmaceuticals's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's FCF Yield % falls into.

Celadon Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Celadon Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-9.413	/	31.143249
	=	-30.22%

Celadon Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-3.731	*	2	/	93.080002
	=	-8.02%

Celadon Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Celadon Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines